LGALS1 and non-small cell lung carcinoma: This study aims to build upon existing research by utilizing ELISA to analyze the concentrations of galectin-1, -3, and -9 in patients’ sera across various stages of the two largest histologic subtypes of NSCLC: adenocarcinoma and squamous cell carcinoma.